首页> 外文期刊>Research Journal of Pharmaceutical Sciences >Preparation, Characterization of Hydrates and Anhydrous Forms of Anti migraine Drug-Frovatriptan Succinate
【24h】

Preparation, Characterization of Hydrates and Anhydrous Forms of Anti migraine Drug-Frovatriptan Succinate

机译:抗偏头痛药物夫来曲普坦琥珀酸酯的水合物和无水形式的制备,表征

获取原文
       

摘要

Frovatriptan succinate (FS) is administrated in monohydrate form. A new dihydrate form of FS is crystallized using acetone and water solvent combination. Interestingly, FS can be crystallized as monohydrate and dihydrate using acetone and water solvent combination. The process conditions are studied and optimized w.r.t. temperature of crystallization and % concentration of water, to get the desired hydrate. The result showed that the concentration of water is deciding factor for the formation of monohydrate and dihydrate of FS. Two different anhydrous forms were produced from two hydrates, by solvent mediated and solid-state transformation techniques. Effect of relative humidity on the anhydrous forms is also investigated. On exposure to humidity both the anhydrous forms are found to be unstable and convert to their corresponding hydrated form. Two hydrated forms and the two anhydrous forms obtained are characterized using X-Ray Powder Diffraction (XRPD), Differential Scanning Calorimetry (DSC), Thermogravimetric Analysis (TGA) and Fourier Transform Infra-red (FTIR).
机译:琥珀酸夫拉曲普坦(FS)以一水合物形式给药。一种新的二水合物形式的FS使用丙酮和水溶剂的组合进行结晶。有趣的是,FS可以使用丙酮和水溶剂的组合结晶为一水合物和二水合物。研究和优化工艺条件结晶温度和水的%浓度,以获得所需的水合物。结果表明,水的浓度是形成FS一水合物和二水合物的决定因素。通过溶剂介导和固态转化技术,由两种水合物制得两种不同的无水形式。还研究了相对湿度对无水形式的影响。暴露于湿气中,发现两种无水形式都是不稳定的,并转化为其相应的水合形式。使用X射线粉末衍射(XRPD),差示扫描量热法(DSC),热重分析(TGA)和傅里叶变换红外(FTIR)对两种水合形式和两种无水形式进行表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号